From the Biotech Board at IHUB CLSC Update
clsc - Update
Currently in talks with two companies for EU. Cobalis would like one company to handle all sales in the EU.
They have been in talks for Japan for a long time. This is moving very slowly. As Urche had mentioned Japan and the EU may be the best markets for their product.
Still in talks in the US. They would like to hurry up and wrap this up so that who ever they partner with can assist with the 2nd phase 3 trial tha will start early next year.
I asked if we could expect this as a xmas present and he just laughed and said I sure hope so.
Expecting to have a trial results in a published paper soon.
Cobalis currently has 26 millions shares outstanding including all warrants, etc...
Currently on target to sell drug in early 2006 in Australia with partner trendtrader
About trendtrade
Trendtrade International is a business development and export management firm offering international product manufacturers and distributors global trading solutions in sourcing, commercializing, launching and managing premium brands and products in the Pharmaceutical, OTC, and Health & Beauty sector within new international markets. Trendtrade carefully selects and builds brands that are market leaders in their product category and have global market potential. Based in Sydney Australia, Trendtrade has an established network of retail, wholesale, and specialist distributors providing distribution through pharmacy, grocery and other mass market channels in various territories throughout the world, including Australia and New Zealand, United Kingdom, South East Asia, Middle East, Canada and Southern Africa.
Randy
